12 Monthly Call

Monthly Call
May 7, 2015
Bharat Forge
Code:
BHAFOR
CMP:
| 1254.75
Comment:
Testing the Green support line.
Action:
Buy in the range of 1230-1240
Reco Date:
May 7, 2015
Stop-loss:
| 1175
Targets:
| 1330 / higher
Biocon
Code:
BIOCON
CMP:
| 452.65
Comment:
Making higher top higher

bottom, now testing Green
support line.
Action:
Buy in the range of 444-449
Reco Date:
May 7, 2015
Stop-loss:
| 425
Targets:
| 494 / higher
ICICI Securities Ltd. | Retail Equity Research
Strategy Follow Up
Date
Scrip
Product
Strategy
Recommended Price
Target
SL
Apr-15
Eveready
Cash
Buy
269.00
294.00
248.00
Apr-15
Gati
Lupin
Cash
Cash
Buy
Buy
222.00
260.00
205.00
1995.00
2,180.00
1,890.00
Apr-15
Gain/Loss % Comment
9.50
9.00
-5.50
Target Achieved
Book profit at 241.50
Stoploss Triggered
NOTES:
Please execute the recommendation within the prescribed range provided in the report
Once the recommendation is executed, it is advisable to keep strict stop loss as provided in
the report on closing basis
We adapt a trading strategy of booking 50% profit when the position is in profit by 5-7% and
trail stoploss on remaining position to the entry point
In recommendations where it is advised to buy on declines, if the target price is hit before
activation of the call in prescribed range then the recommendation is considered not initiated.
The recommendations are valid only for the month and are to be squared off by the end of the
month. In case we intend to carry forward the position, it will be communicated through
separate mail.
Trading Portfolio allocation

It Product
is recommended
to spread
out the trading corpus in a proportionate manner between the
Recommended
wise Trading Portfolio
allocation
various technical research products.

Please avoid allocating the entire trading corpus to a single stock or a single product segment.
Within each product segment it is advisable to allocate equal amount to each
recommendation.
For example: The Daily Calls product carries 3 to 4 intraday recommendations. It is advisable
to allocate equal amount to each recommendation
Products
Allocations
Product wise
Max allocation
allocation
in 1 stock
Return Objective
Number of Calls
Frontline Stocks
Mid-cap stocks
Duration
Daily Calls
8%
2-3%
3-4 Stocks
0.50-1%
2-3%
Intraday
Short term Delivery
6%
3-5%
7-10 p.m
4-5%
7-10%
Opportunity based
Weekly Calls
8%
3-5%
1-2 Stocks
5-7%
7-10%
1 Week
Weekly Technical
8%
3-5%
1-2 Stocks
5-7%
7-10%
1 Week
Monthly Call
15%
5%
2-3 Stocks
7-10%
10-15%
1 Month
Monthly Technical
15%
2-4%
5-8 Stocks
7-10%
10-15%
1 Month
Techno Funda
15%
5-10%
1-2 Stocks
10% and above
15% and above
6 Months
Technical Breakout
15%
5-10%
1-2 Stocks
10% and above
15% and above
3-6 Months
Cash in Hand
10%
100%
Pankaj Pandey
Head Research
ICICIdirect.com Technical Desk,
ICICI Securities Limited,
1st Floor, Akruti Trade Centre,
Road No 7, MIDC
Andheri (East)
Mumbai 400 093
[email protected]
[email protected]
Disclaimer
ANALYST CERTIFICATION
We /I, Dharmesh Shah, Dipesh Daga, Nitin Kunte, Pabitro Mukherjee Research Analysts, authors and the names subscribed to this report, hereby certify that all of
the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation
was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report.
Terms & conditions and other disclosures:

ICICI Securities Limited (ICICI Securities) is a full-service, integrated investment banking and is, inter alia, engaged in the business of stock brokering and
distribution of financial products. ICICI Securities is a wholly-owned subsidiary of ICICI Bank which is Indias largest private sector bank and has its various
subsidiaries engaged in businesses of housing finance, asset management, life insurance, general insurance, venture capital fund management, etc. (associates),
the details in respect of which are available on www.icicibank.com.
ICICI Securities is one of the leading merchant bankers/ underwriters of securities and participate in virtually all securities trading markets in India. We and our
associates might have investment banking and other business relationship with a significant percentage of companies covered by our Investment Research
Department. ICICI Securities generally prohibits its analysts, persons reporting to analysts and their relatives from maintaining a financial interest in the securities or
derivatives of any companies that the analysts cover.
The information and opinions in this report have been prepared by ICICI Securities and are subject to change without any notice. The report and information
contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part
or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ICICI Securities. While we would endeavour to update
the information herein on a reasonable basis, ICICI Securities is under no obligation to update or keep the information current. Also, there may be regulatory,
compliance or other reasons that may prevent ICICI Securities from doing so. Non-rated securities indicate that rating on a particular security has been suspended
temporarily and such suspension is in compliance with applicable regulations and/or ICICI Securities policies, in circumstances where ICICI Securities might be
acting in an advisory capacity to this company, or in certain other circumstances.
This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its
accuracy or completeness guaranteed. This report and information herein is solely for informational purpose and shall not be used or considered as an offer
document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously,
not all customers may receive this report at the same time. ICICI Securities will not treat recipients as customers by virtue of their receiving this report. Nothing in
this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific
circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment
decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of
independent judgment by any recipient. The recipient should independently evaluate the investment risks. The value and return on investment may vary because
of changes in interest rates, foreign exchange rates or any other reason. ICICI Securities accepts no liabilities whatsoever for any loss or damage of any kind arising
out of the use of this report. Past performance is not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to
understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking
statements are not predictions and may be subject to change without notice.
ICICI Securities or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the
subject company for any other assignment in the past twelve months.
ICICI Securities or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months
from the date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking,
brokerage services or other advisory service in a merger or specific transaction.
ICICI Securities or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage
services from the companies mentioned in the report in the past twelve months.
ICICI Securities encourages independence in research report preparation and strives to minimize conflict in preparation of research report. ICICI Securities or its
analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the
research report. Accordingly, neither ICICI Securities nor Research Analysts have any material conflict of interest at the time of publication of this report.
It is confirmed that Dharmesh Shah, Dipesh Daga, Nitin Kunte, Pabitro Mukherjee Research Analysts of this report have not received any compensation from the
companies mentioned in the report in the preceding twelve months.
Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions.
ICICI Securities or its subsidiaries collectively or Research Analysts do not own 1% or more of the equity securities of the Company mentioned in the report as of
the last day of the month preceding the publication of the research report.
Since associates of ICICI Securities are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various
companies including the subject company/companies mentioned in this report.

12 Monthly Call

Uploaded by

Copyright:

Available Formats

12 Monthly Call

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

12 Monthly Call

Uploaded by

Copyright:

Available Formats

Monthly Call

Testing the Green support line.

Buy in the range of 1230-1240

Making higher top higher

Buy in the range of 444-449

ICICI Securities Ltd. | Retail Equity Research

Trading Portfolio allocation

various technical research products.

Short term Delivery

10% and above

15% and above

10% and above

15% and above

ICICI Securities Ltd. | Retail Equity Research

ICICI Securities Ltd. | Retail Equity Research

Terms & conditions and other disclosures:

ICICI Securities Ltd. | Retail Equity Research

You might also like